Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-19 Sale | 2024-11-20 8:00 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 27,389 | $22.41 | $613,826 | 6,905,851 (Indirect Direct) | View |
| 2024-11-19 Sale | 2024-11-20 7:57 pm | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 4,156 | $22.41 | $93,137 | 93,758 (Direct) | View |
| 2024-09-13 Sale | 2024-09-17 6:44 pm | BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR Group Co. Inc. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner | 5,800,000 | $25.75 | $149,350,000 | 25,260,971 (Indirect) | View |
| 2024-08-19 Sale | 2024-08-20 6:31 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 27,389 | $24.69 | $676,256 | 7,520,470 (Indirect Direct) | View |
| 2024-08-19 Sale | 2024-08-20 6:27 pm | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 4,155 | $24.69 | $102,590 | 359,035 (Direct) | View |
| 2024-06-03 Sale | 2024-06-05 4:53 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,500 | $30.32 | $75,793 | 9,000 (Indirect Direct) | View |
| 2024-03-01 Sale | 2024-03-05 4:00 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,500 | $34 | $85,000 | 11,500 (Indirect Direct) | View |
| 2024-02-15 Sale | 2024-02-20 4:03 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $37.75 | $110,041 | 98,458 (Indirect Direct) | View |
| 2021-12-28 Purchase | 2024-02-13 4:05 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 3,433 | $12.96 | $44,476 | 5,197 (Indirect Direct) | View |
| 2021-12-28 Purchase | 2024-02-13 4:00 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 3,433 | $12.96 | $44,476 | 3,433 (Indirect) | View |
| 2024-01-16 Sale | 2024-01-18 4:10 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $37.97 | $110,683 | 97,940 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-10 Option Award | 2024-12-12 7:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 121,951 | $0 | 121,951 (Direct) | View |
| 2024-12-10 Option Award | 2024-12-12 7:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 42,683 | $0 | 42,683 (Direct) | View |
| 2024-12-10 Option Award | 2024-12-12 7:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO | 50,000 | $0 | 427,987 (Direct) | View |
| 2024-11-16 Exercise | 2024-11-19 6:15 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 111,074 | $0 | 7,492,322 (Direct) | View |
| 2024-11-16 Tax Withholding | 2024-11-19 6:15 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 28,148 | $23.72 | 7,492,322 (Direct) | View |
| 2024-11-16 Tax Withholding | 2024-11-19 6:13 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO | 17,936 | $23.72 | 377,987 (Direct) | View |
| 2024-11-16 Exercise | 2024-11-19 6:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 51,598 | $0 | 345,958 (Direct) | View |
| 2024-11-16 Tax Withholding | 2024-11-19 6:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 13,077 | $23.72 | 345,958 (Direct) | View |
| 2024-08-16 Exercise | 2024-08-20 6:31 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 111,074 | $0 | 7,520,470 (Direct) | View |
| 2024-08-16 Tax Withholding | 2024-08-20 6:31 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 28,148 | $24.4 | 7,520,470 (Direct) | View |
| 2024-08-16 Exercise | 2024-08-20 6:27 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 51,594 | $0 | 359,035 (Direct) | View |
| 2024-08-16 Tax Withholding | 2024-08-20 6:27 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 13,077 | $24.4 | 359,035 (Direct) | View |
| 2024-08-16 Tax Withholding | 2024-08-20 6:24 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO | 17,936 | $24.4 | 395,923 (Direct) | View |
| 2024-08-06 Option Award | 2024-08-08 4:39 pm | N/A 2034-08-05 | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO | 22,163 | $0 | 417,019 (Direct) | View |
Ownership | 2024-07-29 8:16 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO | 0 | $0 | 706,547 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:42 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:42 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:40 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:39 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:39 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:39 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:39 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 26,014 | $0 | 1,126,079 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:38 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:38 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:36 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:36 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:35 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:34 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | AGUIAR ERIC Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2024-05-16 Exercise | 2024-05-17 4:11 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 121,334 | $0 | 7,576,007 (Direct) | View |
| 2024-05-16 Tax Withholding | 2024-05-17 4:11 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 30,748 | $31.04 | 7,576,007 (Direct) | View |
| 2024-05-16 Exercise | 2024-05-17 4:09 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 55,014 | $0 | 376,112 (Direct) | View |
| 2024-05-16 Tax Withholding | 2024-05-17 4:09 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 13,943 | $31.04 | 376,112 (Direct) | View |
| 2024-03-12 Option Award | 2024-03-14 4:00 pm | N/A 2034-03-11 | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 358,728 | $0 | 358,728 (Direct) | View |
| 2024-03-12 Option Award | 2024-03-14 4:00 pm | N/A 2034-03-11 | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 122,720 | $0 | 122,720 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 4:04 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 89,992 | $0 | 282,777 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-21 4:04 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 18,919 | $37.21 | 282,777 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 4:04 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 3,760 | $0 | 1,230,085 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-21 4:04 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 1,509 | $37.21 | 1,230,085 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 4:03 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 204,498 | $0 | 7,293,167 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-21 4:03 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 47,922 | $37.21 | 7,293,167 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 4:03 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $0 | 98,458 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 4:03 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $8.45 | 98,458 (Direct) | View |
Ownership | 2024-02-13 4:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 0 | $0 | 5,197 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 4:10 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $0 | 97,940 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 4:10 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $8.45 | 97,940 (Direct) | View |